They found that increasing the levels of GPX4 might counteract the effects of TMEM44-AS1 elimination, hence promoting the growth, movement, and penetration of esophageal squamous cell carcinoma (ESCC) cells via ferroptosis. The gene discussed is GPX4; the disease is esophageal squamous cell carcinoma.